Evidence map›Paper›PMID 29540179›Full record

SynthesisWorld journal of surgical oncology2018

The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature.

Dimitrios Schizas, Ioannis I Lazaridis, Demetrios Moris, Aikaterini Mastoraki, Lazaros-Dimitrios Lazaridis, Diamantis I Tsilimigras, Nikolaos Charalampakis, Theodore Liakakos

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in World journal of surgical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Multimodal therapy for oligometastases after curative esophagectomy for esophageal cancer.Esophagus : official journal of the Japan Esophageal Society · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Solitary recurrence at intercostal drain site in oesophageal adenocarcinoma.Indian journal of thoracic and cardiovascular surgery · 2020
    Article
  19. Article
  20. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Dimitrios SchizasFirst Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, 17 Agiou Thoma Str., Goudi, 11527, Athens, Greece. schizasad@gmail.com.ORCID http://orcid.org/0000-0002-7046-0112
Ioannis I LazaridisDepartment of Surgery, University Hospital Basel, Basel, Switzerland.
Demetrios MorisFirst Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, 17 Agiou Thoma Str., Goudi, 11527, Athens, Greece.
Aikaterini MastorakiFourth Department of Surgery, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Lazaros-Dimitrios LazaridisHepatogastroenterology Unit, Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Diamantis I TsilimigrasSchool of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Nikolaos CharalampakisFirst Department of Medical Oncology, Henry Dunant Hospital Center, Athens, Greece.
Theodore LiakakosFirst Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, 17 Agiou Thoma Str., Goudi, 11527, Athens, Greece.
National and Kapodistrian University of Athens · GRHenry Dunant Hospital · GRUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite the improvements in the early detection and treatment of non-metastatic esophageal cancer, more than half of patients undergoing a curative treatment for esophageal cancer will develop recurrence within three years. The prognosis of these patients is poor. However, a wide range in overall survival has been reported, depending on the pattern of recurrence, and no optimal treatment strategy following recurrence has yet been uniformly accepted.

aimIn this article, we aimed to systematically review the literature for the role of surgical resection of metachronous distant metastasis following primary treatment of esophageal cancer. Furthermore, we discuss possible factors that could possibly predict which patients may benefit from a surgical approach. A comprehensive literature search was conducted in PubMed using combinations of keywords.

resultsPatients with recurrence may benefit of a multimodality treatment. Regarding the isolated recurrence of esophageal cancer in solid visceral organs, operative intervention has been proposed as a treatment that may offer a survival benefit in an individual basis. No definitive conclusions regarding the potential survival advantage offered by the surgical treatment of solitary recurrent lesions can be drawn. However, recent improvements in surgical treatment and optimization of perioperative management guarantee an acceptable operative risk, making surgical resection of solitary recurrence lesions a considerable therapeutic option.

conclusionsIt can be conferred from the available studies that the surgical treatment of isolated recurrence from esophageal cancer may offer a survival benefit for properly selected patients. Prospective, multicenter studies might be useful to gain a better insight into those factors that affect selection of patients to take benefit from an operative intervention.

Indexed as

Esophageal NeoplasmsEsophagectomyHumansNeoplasm Recurrence, LocalPrognosisSurvival RateEsophageal cancerIsolated recurrenceMetastasectomyMetastasisSolitary lesionsSurgical management

Identifiers

PMID29540179
PMCPMC5853115
OpenAlexW2800354923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.